Variant report

Variant	nsv828141
Chromosome Location	chr1:10695477-10704197
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:145)
CpG islands
(count:977)
Chromatin interactive
region (count:11)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:145 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr1:10699434-10699676	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr1:10701393-10701600	HepG2	liver:	n/a	n/a
3	CEBPB	chr1:10695597-10696010	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr1:10695688-10695932	HepG2	liver:	n/a	n/a
5	CEBPB	chr1:10695625-10695985	IMR90	lung:	n/a	n/a
6	CHD1	chr1:10699506-10699568	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr1:10700080-10700230	SK-N-SH_RA	brain:	n/a	chr1:10700209-10700222
8	CTCF	chr1:10700500-10700650	SK-N-SH_RA	brain:	n/a	n/a
9	CTCF	chr1:10696156-10696234	NHEK	skin:	n/a	n/a
10	CTCF	chr1:10699420-10699570	HRPEpiC	eye:	n/a	n/a
11	CTCF	chr1:10699360-10699510	HA-sp	spinal cord:	n/a	n/a
12	CTCF	chr1:10699460-10699610	AoAF	blood vessel:	n/a	n/a
13	CTCF	chr1:10698400-10698550	NHDF-neo	bronchial:	n/a	n/a
14	CTCF	chr1:10698120-10698270	HPF	lung:	n/a	n/a
15	CTCF	chr1:10698260-10698410	HBMEC	blood vessel:	n/a	n/a
16	CTCF	chr1:10697630-10697654	LNCaP	prostate:	n/a	n/a
17	CTCF	chr1:10695800-10695950	SAEC	small airway:	n/a	n/a
18	CTCF	chr1:10696120-10696270	SAEC	small airway:	n/a	chr1:10696254-10696267
19	CTCF	chr1:10696060-10696210	HEEpiC	esophagus:	n/a	chr1:10696101-10696110
20	CTCF	chr1:10699440-10699590	HCFaa	heart:	n/a	n/a
21	CTCF	chr1:10698720-10698870	AoAF	blood vessel:	n/a	n/a
22	CTCF	chr1:10699420-10699570	HBMEC	blood vessel:	n/a	n/a
23	CTCF	chr1:10698220-10698510	HA-sp	spinal cord:	n/a	n/a
24	CTCF	chr1:10696180-10696330	HMEC	breast:	n/a	chr1:10696254-10696267
25	CTCF	chr1:10699487-10699589	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr1:10698280-10698430	HCPEpiC	choroid plexus:	n/a	n/a
27	CTCF	chr1:10700460-10700610	SK-N-SH_RA	brain:	n/a	n/a
28	CTCF	chr1:10696100-10696250	HMEC	breast:	n/a	chr1:10696101-10696110
29	CTCF	chr1:10700172-10700264	H1-hESC	embryonic stem cell:	n/a	chr1:10700209-10700222
30	CTCF	chr1:10699380-10699530	AG09319	gingival:	n/a	n/a
31	E2F4	chr1:10695534-10695719	MCF10A-Er-Src	breast:	n/a	n/a
32	E2F6	chr1:10699361-10700329	H1-hESC	embryonic stem cell:	n/a	chr1:10700269-10700278
33	E2F6	chr1:10699339-10699954	H1-hESC	embryonic stem cell:	n/a	n/a
34	EP300	chr1:10699735-10702043	SK-N-SH	brain:	n/a	chr1:10701367-10701374
35	EP300	chr1:10695983-10696372	T-47D	breast:	n/a	n/a
36	EP300	chr1:10695153-10695842	T-47D	breast:	n/a	chr1:10695588-10695601 chr1:10695599-10695615 chr1:10695643-10695650 chr1:10695246-10695262
37	EP300	chr1:10700319-10700776	SK-N-SH_RA	brain:	n/a	n/a
38	EP300	chr1:10695894-10696424	T-47D	breast:	n/a	n/a
39	EP300	chr1:10700327-10700667	SK-N-SH_RA	brain:	n/a	n/a
40	FOS	chr1:10695315-10696027	MCF10A-Er-Src	breast:	n/a	chr1:10695427-10695437
41	FOS	chr1:10695404-10696037	MCF10A-Er-Src	breast:	n/a	chr1:10695427-10695437
42	FOS	chr1:10695308-10695958	MCF10A-Er-Src	breast:	n/a	chr1:10695427-10695437
43	FOS	chr1:10695339-10695989	MCF10A-Er-Src	breast:	n/a	chr1:10695427-10695437
44	FOXA1	chr1:10695458-10695755	T-47D	breast:	n/a	n/a
45	FOXA1	chr1:10696099-10696364	T-47D	breast:	n/a	n/a
46	FOXA1	chr1:10695305-10695730	T-47D	breast:	n/a	n/a
47	FOXA2	chr1:10695473-10695669	A549	lung:	n/a	n/a
48	FOXP2	chr1:10695118-10696024	SK-N-MC	brain:	n/a	n/a
49	FOXP2	chr1:10700266-10700726	SK-N-MC	brain:	n/a	n/a
50	GABPA	chr1:10698518-10699036	H1-hESC	embryonic stem cell:	n/a	n/a

(count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:10698719-10698769	Jurkat	blood:	n/a
2	chr1:10698719-10698769	Jurkat	blood:	n/a
3	chr1:10699604-10699654	HNPCEpiC	eye:	n/a
4	chr1:10699604-10699654	ECC-1	luminal epithelium:	n/a
5	chr1:10698794-10698844	NHBE	bronchial:	n/a
6	chr1:10697703-10697753	GM12878	blood:	n/a
7	chr1:10697703-10697753	HIPEpiC	eye:	n/a
8	chr1:10698313-10698363	SKMC	muscle:	n/a
9	chr1:10699604-10699654	AG09309	skin:	n/a
10	chr1:10699604-10699654	SK-N-MC	brain:	n/a
11	chr1:10702712-10702762	SK-N-SH_RA	brain:	n/a
12	chr1:10698794-10698844	BE2_C	brain:	n/a
13	chr1:10703231-10703281	HPAEpiC	pulmonary alveolar:	n/a
14	chr1:10698794-10698844	CMK	blood:	n/a
15	chr1:10702137-10702187	HepG2	liver:	n/a
16	chr1:10699975-10700025	SK-N-MC	brain:	n/a
17	chr1:10698313-10698363	HCPEpiC	choroid plexus:	n/a
18	chr1:10702712-10702762	HRE	kidney:	n/a
19	chr1:10700647-10700697	HepG2	liver:	n/a
20	chr1:10702712-10702762	HAEpiC	amniotic membrane:	n/a
21	chr1:10698794-10698844	HNPCEpiC	eye:	n/a
22	chr1:10700647-10700697	MCF-7	breast:	n/a
23	chr1:10702712-10702762	K562	blood:	n/a
24	chr1:10698794-10698844	SAEC	small airway:	n/a
25	chr1:10697703-10697753	CMK	blood:	n/a
26	chr1:10699958-10700008	PrEC	prostate:	n/a
27	chr1:10703231-10703281	GM12878	blood:	n/a
28	chr1:10699604-10699654	Caco-2	colon:	n/a
29	chr1:10702712-10702762	HUVEC	blood vessel:	n/a
30	chr1:10700647-10700697	Hela-S3	cervix:	n/a
31	chr1:10703231-10703281	AG09319	gingival:	n/a
32	chr1:10699604-10699654	HUVEC	blood vessel:	n/a
33	chr1:10699958-10700008	NHBE	bronchial:	n/a
34	chr1:10702137-10702187	HRE	kidney:	n/a
35	chr1:10699975-10700025	HPAEpiC	pulmonary alveolar:	n/a
36	chr1:10696066-10696116	ovcar-3	ovarian:	n/a
37	chr1:10702712-10702762	HCPEpiC	choroid plexus:	n/a
38	chr1:10702137-10702187	PANC-1	pancreas:	n/a
39	chr1:10699831-10699881	HRPEpiC	eye:	n/a
40	chr1:10699958-10700008	IMR90	lung:	fetal
41	chr1:10699958-10700008	AoSMC	blood vessel:	n/a
42	chr1:10696018-10696068	SKMC	muscle:	n/a
43	chr1:10698794-10698844	Caco-2	colon:	n/a
44	chr1:10696066-10696116	PANC-1	pancreas:	n/a
45	chr1:10702137-10702187	NHBE	bronchial:	n/a
46	chr1:10703231-10703281	HRE	kidney:	n/a
47	chr1:10695686-10695736	RPTEC	kidney:	n/a
48	chr1:10699958-10700008	Caco-2	colon:	n/a
49	chr1:10698313-10698363	Jurkat	blood:	n/a
50	chr1:10697703-10697753	IMR90	lung:	fetal

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:10694311..10696932-chr1:10702215..10704200,2	K562	blood:
2	chr1:10698140..10700728-chr1:10703080..10705863,3	K562	blood:
3	chr1:10698140..10700728-chr1:10703080..10705863,3	K562	blood:
4	chr1:10703132..10705545-chr1:10711056..10713011,2	K562	blood:
5	chr1:10694140..10696229-chr1:10885047..10887221,2	MCF-7	breast:
6	chr1:10698341..10701476-chr1:10701646..10704585,3	MCF-7	breast:
7	chr1:10694311..10696932-chr1:10702215..10704200,2	K562	blood:
8	chr1:10703574..10707168-chr1:10709558..10711927,3	MCF-7	breast:
9	chr1:10574993..10577268-chr1:10694934..10697136,2	MCF-7	breast:
10	chr1:10685500..10687497-chr1:10695365..10698289,2	K562	blood:
11	chr1:10567638..10569716-chr1:10700234..10702656,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DFFA-4	chr1:10698772-10698820	NONHSAT000866
2	lnc-PEX14-4	chr1:10703938-10704151	uc_5_+
3	lnc-DFFA-4	chr1:10697178-10697465	NONHSAT000866
4	lnc-DFFA-5	chr1:10703938-10704151	uc_5_-

No data

Variant related genes	Relation type
ENSG00000272078	TF binding region
CASZ1	TF binding region
ENSG00000272078	CpG island
CASZ1	CpG island
ENSG00000130940	chromatin interactions
ENSG00000272078	chromatin interactions

Extended variants
information (count: 388 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:388 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569814885	chr1:10695568-10695569	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs181276068	chr1:10695603-10695604	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs142038432	chr1:10695608-10695609	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs544495949	chr1:10695619-10695620	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs145608514	chr1:10695661-10695662	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs556864791	chr1:10695686-10695687	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
7	rs577913368	chr1:10695687-10695688	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs534309090	chr1:10695697-10695698	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs61776292	chr1:10695703-10695704	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs545396755	chr1:10695722-10695723	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs560350277	chr1:10695771-10695772	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs527809384	chr1:10695820-10695821	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs543177663	chr1:10695848-10695849	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs561053655	chr1:10695860-10695861	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs531582828	chr1:10695881-10695882	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs549762304	chr1:10695922-10695923	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs72858508	chr1:10695941-10695942	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs531976058	chr1:10695942-10695943	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs145899109	chr1:10695943-10695944	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs565362315	chr1:10695976-10695977	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs535930421	chr1:10695985-10695986	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs115251591	chr1:10696018-10696019	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs547286246	chr1:10696019-10696020	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs538439427	chr1:10696048-10696049	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs567354133	chr1:10696158-10696159	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs556541050	chr1:10696161-10696162	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs148190470	chr1:10696179-10696180	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs545047134	chr1:10696201-10696202	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs141174006	chr1:10696210-10696211	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs572512705	chr1:10696221-10696222	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs543139305	chr1:10696222-10696223	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs561370586	chr1:10696227-10696228	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs72641441	chr1:10696229-10696230	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs543616739	chr1:10696230-10696231	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs565002747	chr1:10696233-10696234	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs532412160	chr1:10696243-10696244	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs547411403	chr1:10696244-10696245	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs558917775	chr1:10696296-10696297	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs577498199	chr1:10696304-10696305	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs529689772	chr1:10696311-10696312	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs547836480	chr1:10696384-10696385	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs150363881	chr1:10696397-10696398	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs138092655	chr1:10696415-10696416	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs373724115	chr1:10696454-10696455	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs557724617	chr1:10696455-10696456	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs571777262	chr1:10696468-10696469	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs539308517	chr1:10696513-10696514	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs554550917	chr1:10696522-10696523	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs572423541	chr1:10696526-10696527	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs533087995	chr1:10696546-10696547	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	22429812	CNVD
Epilepsy	22118685	CNVD
Schizophrenia	22118685	CNVD
Ovarian cancer	21720365	CNVD
Developmental delay	19490664	CNVD
Ewing''s sarcoma	21437220	CNVD
Prader-willi syndrome	18797701	CNVD
periventricular nodular heterotopia	20648244	CNVD
1p36 deletion syndrome	22283845	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Follicular lymphoma	20505157	CNVD
Neuroblastoma	18923524	CNVD
Retinoblastoma	22278416	CNVD
Mental retardation	20152051	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Astrocytoma	17934521	CNVD
Glioblastoma	20031968	CNVD
Acute myeloid leukemia	18000384	CNVD
Glioblastoma multiforme	16951158	CNVD
Neuroblastoma	18574593	CNVD
Glioblastoma multiforme	17369134	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Myoepithelioma	18604193	CNVD
Wilms tumour	19047088	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Soft tissue tumor	16732325	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic myeloid leukemia	21384125	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Neuroblastoma	18923191	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21138945	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian neoplasms	16753589	CNVD
Neuroblastoma	19287153	CNVD
Hepatocellular carcinoma	18929564	CNVD
Melanoma	17363583	CNVD
renal disease	17924346	CNVD
Uveal melanoma	20484589	CNVD
Multiple myeloma	16616336	CNVD
Glioblastoma multiforme	22286061	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	20808228	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:563 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:10632600-10698000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
2	chr1:10651600-10715800	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr1:10660200-10697600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
4	chr1:10664400-10698000	Weak transcription	Primary B cells from cord blood	blood
5	chr1:10681200-10697600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
6	chr1:10685200-10699400	Weak transcription	Aorta	Aorta
7	chr1:10686200-10698000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr1:10687600-10698000	Weak transcription	Small Intestine	intestine
9	chr1:10690200-10696000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr1:10691000-10696200	Enhancers	H1 Cell Line	embryonic stem cell
11	chr1:10691000-10697400	Weak transcription	Gastric	stomach
12	chr1:10691200-10695600	Weak transcription	Fetal Thymus	thymus
13	chr1:10691400-10695600	Enhancers	Breast Myoepithelial Primary Cells	Breast
14	chr1:10691400-10695800	Weak transcription	Monocytes-CD14+_RO01746	blood
15	chr1:10691400-10697400	Weak transcription	Brain Inferior Temporal Lobe	brain
16	chr1:10691400-10698000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
17	chr1:10691600-10695600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr1:10691600-10695800	Enhancers	Ovary	ovary
19	chr1:10691600-10696200	Weak transcription	Primary monocytes fromperipheralblood	blood
20	chr1:10691600-10697200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
21	chr1:10691600-10697400	Weak transcription	Primary T helper cells fromperipheralblood	blood
22	chr1:10691600-10697600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
23	chr1:10691600-10703000	Weak transcription	Primary B cells from peripheral blood	blood
24	chr1:10691600-10706000	Weak transcription	Dnd41	blood
25	chr1:10691800-10697200	Weak transcription	Primary T cells from cord blood	blood
26	chr1:10691800-10697800	Weak transcription	Primary T helper cells PMA-I stimulated	--
27	chr1:10692000-10695800	Weak transcription	Brain Cingulate Gyrus	brain
28	chr1:10692000-10696000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr1:10692000-10696600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
30	chr1:10692000-10697800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
31	chr1:10692200-10695600	Weak transcription	Pancreas	Pancrea
32	chr1:10692400-10699400	Weak transcription	Duodenum Mucosa	Duodenum
33	chr1:10692600-10697200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr1:10692600-10698400	Weak transcription	H9 Cell Line	embryonic stem cell
35	chr1:10692800-10695800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
36	chr1:10693200-10697400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
37	chr1:10693200-10699400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr1:10693400-10696400	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr1:10693600-10697600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr1:10693600-10698000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
41	chr1:10693800-10695600	Weak transcription	Spleen	Spleen
42	chr1:10693800-10696800	Enhancers	Skeletal Muscle Male	skeletal muscle
43	chr1:10693800-10697400	Weak transcription	Sigmoid Colon	Sigmoid Colon
44	chr1:10694000-10697200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr1:10694200-10696200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
46	chr1:10694200-10696600	Enhancers	Esophagus	oesophagus
47	chr1:10694200-10696600	Genic enhancers	Fetal Muscle Leg	muscle
48	chr1:10694200-10696600	Bivalent Enhancer	Fetal Stomach	stomach
49	chr1:10694200-10697800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
50	chr1:10694400-10695600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links